LS Scientific Drives Innovation in Nigeria's Pharma Sector

LS Scientific, represented by Managing Director Murewa Odunjo, is advocating for innovation as a key driver of growth in Nigeria's pharmaceutical sector, which is estimated to be worth $2 billion. The company participated in the Pharma West Africa 2026 event held in April in Lagos, where industry stakeholders gathered to discuss challenges affecting the sector's sustainable growth.

The firm highlighted that the demand for locally manufactured medicines is increasing, but weak quality control and infrastructure issues are limiting access to modern laboratory systems. Stricter regulatory standards further hinder the sector's global competitiveness.

At the event, LS Scientific showcased advanced laboratory technologies from international partners, including Erweka (Germany), Metrohm (Switzerland), and others. Odunjo disclosed that the company is introducing a financing scheme to ease capital investment burdens on pharmaceutical firms, allowing them to acquire major laboratory equipment through a six-payment plan.

The future growth of Nigeria's pharmaceutical sector depends on sustained investment in infrastructure and stronger collaboration across the value chain.